The Effect of Nanocurcumin Administration on Plasma Malondialdehyde (MDA) Levels in Pregnant Wistar Rats (Rattus norvegicus) as a Preeclampsia Model: Pengaruh Pemberian Nano Kurkumin terhadap Kadar Malondialdehyde (MDA) Plasma Darah Pada Tikus Wistar (Rattus norvegicus) Bunting Model Preeklampsia

Subandi Subandi; Laras Indah Sari; Nurdiana Nurdiana

doi:10.47679/makein.2025226

Published: 9 January 2025

The Effect of Nanocurcumin Administration on Plasma Malondialdehyde (MDA) Levels in Pregnant Wistar Rats (Rattus norvegicus) as a Preeclampsia Model: Pengaruh Pemberian Nano Kurkumin terhadap Kadar Malondialdehyde (MDA) Plasma Darah Pada Tikus Wistar (Rattus norvegicus) Bunting Model Preeklampsia

dr. Subandi, SpOG(K)
Laras Indah Sari
Prof. Dr. dr. Nurdiana, M.Kes

Vol. 6 No. 1: 2025 | Pages: 35-42

DOI: 10.47679/makein.2025226 Reader: 515 times PDF Download: 248 times

Abstract

Preeclampsia is a pregnancy complication associated with oxidative stress and increased levels of malondialdehyde (MDA), leading to endothelial dysfunction and impaired placental perfusion. Nanocurcumin possesses antioxidant properties that can mitigate oxidative stress; however, its effectiveness in reducing MDA levels in preeclampsia requires further investigation. This study aims to evaluate the effect of nanocurcumin administration on plasma MDA levels in pregnant Rattus norvegicus models of preeclampsia induced using Nw-Nitro-L-Arginine Methyl Ester (L-NAME). A total of 24 pregnant Wistar rats were divided into six groups: negative control (K-), positive control (K+), and four treatment groups receiving nanocurcumin at doses of 25 mg/KgBW (P1), 50 mg/KgBW (P2), 100 mg/KgBW (P3), and 200 mg/KgBW (P4). Preeclampsia was induced by administering L-NAME (125 mg/KgBW) for six consecutive days, followed by nanocurcumin treatment. Plasma MDA levels were measured using the Thiobarbituric Acid (TBA) assay and analyzed using the Kruskal-Wallis test and post-hoc Mann-Whitney test (p < 0.05). Nanocurcumin administration at 25 mg/KgBW and 50 mg/KgBW significantly reduced MDA levels compared to the preeclampsia group without treatment (p = 0.042, p < 0.05). However, a high dose of 200 mg/KgBW increased MDA levels, indicating a potential pro-oxidant effect. Low to moderate doses of nanocurcumin effectively reduced MDA levels in the preeclampsia model, but further studies are necessary to determine the optimal dosage and its safety in humans.

Abstrak: Preeklamsia merupakan komplikasi kehamilan yang berhubungan dengan stres oksidatif dan peningkatan kadar malondialdehyde (MDA), yang menyebabkan disfungsi endotel dan gangguan perfusi plasenta. Nanokurkumin memiliki sifat antioksidan yang dapat mengurangi stres oksidatif, tetapi efektivitasnya dalam menurunkan kadar MDA pada preeklamsia masih perlu dikaji lebih lanjut. Penelitian ini bertujuan untuk mengevaluasi pengaruh pemberian nanokurkumin terhadap kadar MDA plasma pada tikus putih (Rattus norvegicus) bunting model preeklamsia yang diinduksi menggunakan Nw-Nitro-L-Arginine Methyl Ester (L-NAME). Sebanyak 24 ekor tikus Wistar bunting dibagi menjadi enam kelompok: kontrol negatif (K-), kontrol positif (K+), serta empat kelompok perlakuan yang menerima nanokurkumin dengan dosis 25 mg/KgBW (P1), 50 mg/KgBW (P2), 100 mg/KgBW (P3), dan 200 mg/KgBW (P4). Induksi preeklamsia dilakukan dengan pemberian L-NAME (125 mg/KgBW) selama enam hari, diikuti pemberian nanokurkumin. Kadar MDA plasma diukur menggunakan metode Thiobarbituric Acid (TBA) assay dan dianalisis dengan uji Kruskal-Wallis dan post-hoc Mann-Whitney (p < 0.05). Pemberian nanokurkumin 25 mg/KgBW dan 50 mg/KgBW secara signifikan menurunkan kadar MDA dibandingkan kelompok preeklamsia tanpa terapi (p = 0.042, p < 0.05). Namun, dosis tinggi (200 mg/KgBW) justru meningkatkan kadar MDA, menunjukkan efek pro-oksidan. Nanokurkumin dosis rendah hingga sedang efektif dalam menurunkan kadar MDA pada model preeklamsia, tetapi studi lanjutan diperlukan untuk menentukan dosis optimal dan keamanannya pada manusia.

References

Aggarwal, B. B., & Sung, B. (2009). Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends in pharmacological sciences, 30(2), 85–94. https://doi.org/10.1016/j.tips.2008.11.002
Alizadeh, M., & Kheirouri, S. (2019). Curcumin against advanced glycation end products (AGEs) and AGEs-induced detrimental agents. Critical reviews in food science and nutrition, 59(7), 1169–1177. https://doi.org/10.1080/10408398.2017.1396200
American Veterinary Medical Association (AVMA). (2020). Guidelines for the euthanasia of animals: 2020 edition. Schaumburg, IL: AVMA.
Aouache, R., Biquard, L., Vaiman, D., & Miralles, F. (2018). Oxidative Stress in Preeclampsia and Placental Diseases. International journal of molecular sciences, 19(5), 1496. https://doi.org/10.3390/ijms19051496
Ayala, A., Muñoz, M. F., & Argüelles, S. (2014). Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative medicine and cellular longevity, 2014, 360438. https://doi.org/10.1155/2014/360438
Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, A., & Maitra, A. (2007). Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. Journal of nanobiotechnology, 5, 3. https://doi.org/10.1186/1477-3155-5-3
Brown, M. A., Magee, L. A., Kenny, L. C., Karumanchi, S. A., McCarthy, F. P., Saito, S., Hall, D. R., Warren, C. E., Adoyi, G., Ishaku, S., & International Society for the Study of Hypertension in Pregnancy (ISSHP) (2018). Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. Hypertension (Dallas, Tex. : 1979), 72(1), 24–43. https://doi.org/10.1161/HYPERTENSIONAHA.117.10803
Burton, G. J., & Jauniaux, E. (2011). Oxidative stress. Best practice & research. Clinical obstetrics & gynaecology, 25(3), 287–299. https://doi.org/10.1016/j.bpobgyn.2010.10.016
Calsolaro, V., & Edison, P. (2016). Alterations in Glucose Metabolism in Alzheimer's Disease. Recent patents on endocrine, metabolic & immune drug discovery, 10(1), 31–39. https://doi.org/10.2174/1872214810666160615102809
Cindrova-Davies, T., Fogarty, N. M. E., Jones, C. J. P., Kingdom, J., & Burton, G. J. (2018). Evidence of oxidative stress-induced senescence in mature, post-mature and pathological human placentas. Placenta, 68, 15–22. https://doi.org/10.1016/j.placenta.2018.06.307
de Alwis, N., Binder, N. K., Beard, S., Mangwiro, Y. T., Kadife, E., Cuffe, J. S., Keenan, E., Fato, B. R., Kaitu'u-Lino, T. J., Brownfoot, F. C., Marshall, S. A., & Hannan, N. J. (2022). The L-NAME mouse model of preeclampsia and impact to long-term maternal cardiovascular health. Life science alliance, 5(12), e202201517. https://doi.org/10.26508/lsa.202201517
de Lucca, L., Rodrigues, F., Jantsch, L. B., Kober, H., Neme, W. S., Gallarreta, F. M. P., & Gonçalves, T. L. (2016). Delta-aminolevulinate dehydratase activity and oxidative stress markers in preeclampsia. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 84, 224–229. https://doi.org/10.1016/j.biopha.2016.09.033
Esperanza, Y., Prabowo, S., & Handajani, F.. (2021). Pengaruh Pemberian Curcumin Terhadap Perbaikan Fungsi Hepar Tikus Putih (Rattus Novergicus) yang diinduksi Parasetamol Dosis Tinggi. Jurnal Ilmiah Kedokteran Wijaya Kusuma, 10(2), 208. https://doi.org/10.30742/jikw.v10i2.1250
Flecknell, P. A. (2015). Laboratory animal anaesthesia (4th ed.). Academic Press.
Ganugula, R., Arora, M., Jaisamut, P., Wiwattanapatapee, R., Jørgensen, H. G., Venkatpurwar, V. P., Zhou, B., Rodrigues Hoffmann, A., Basu, R., Guo, S., & Majeti, N. V. R. K. (2017). Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus. British journal of pharmacology, 174(13), 2074–2084. https://doi.org/10.1111/bph.13816
Gong, P., Liu, M., Hong, G., Li, Y., Xue, P., Zheng, M., Wu, M., Shen, L., Yang, M., Diao, Z., & Hu, Y. (2016). Curcumin improves LPS-induced preeclampsia-like phenotype in rat by inhibiting the TLR4 signaling pathway. Placenta, 41, 45–52. https://doi.org/10.1016/j.placenta.2016.03.002
Jara, C., Torres, A. K., Park-Kang, H. S., Sandoval, L., Retamal, C., Gonzalez, A., Ricca, M., Valenzuela, S., Murphy, M. P., Inestrosa, N. C., & Tapia-Rojas, C. (2025). Curcumin Improves Hippocampal Cell Bioenergetics, Redox and Inflammatory Markers, and Synaptic Proteins, Regulating Mitochondrial Calcium Homeostasis. Neurotoxicity research, 43(1), 3. https://doi.org/10.1007/s12640-024-00726-y
Kanasaki, K., Palmsten, K., Sugimoto, H., Ahmad, S., Hamano, Y., Xie, L., Parry, S., Augustin, H. G., Gattone, V. H., Folkman, J., Strauss, J. F., & Kalluri, R. (2008). Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature, 453(7198), 1117–1121. https://doi.org/10.1038/nature06951
Karthikeyan, A., Senthil, N., & Min, T. (2020). Nanocurcumin: A Promising Candidate for Therapeutic Applications. Frontiers in pharmacology, 11, 487. https://doi.org/10.3389/fphar.2020.00487
Mert, I., Oruc, A. S., Yuksel, S., Cakar, E. S., Buyukkagnici, U., Karaer, A., & Danisman, N. (2012). Role of oxidative stress in preeclampsia and intrauterine growth restriction. The journal of obstetrics and gynaecology research, 38(4), 658–664. https://doi.org/10.1111/j.1447-0756.2011.01771.x
Mishra, V. K., Mohammad, G., & Mishra, S. K. (2008). Downregulation of telomerase activity may enhanced by nanoparticle mediated curcumin delivery. Digest Journal of Nanomaterials and Biostructures, 3(4), 163–169.
Myatt L. (2010). Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta, 31 Suppl(Suppl), S66–S69. https://doi.org/10.1016/j.placenta.2009.12.021
National Research Council (NRC). (2011). Guide for the care and use of laboratory animals (8th ed.). National Academies Press.
Nelson, K. M., Dahlin, J. L., Bisson, J., Graham, J., Pauli, G. F., & Walters, M. A. (2017). The Essential Medicinal Chemistry of Curcumin. Journal of medicinal chemistry, 60(5), 1620–1637. https://doi.org/10.1021/acs.jmedchem.6b00975
Nurseta, T., Irwanto, Y., Wiyasa, I. W., Rahajeng, R., Imelda, I., & Ratnawati, P. A. (2018). Curcumin induces apoptosis in trophoblast model cell line. Medical Journal of Indonesia, 27(2), 87-93. https://doi.org/10.13181/mji.v27i2.1821
Perrone, D., Ardito, F., Giannatempo, G., Dioguardi, M., Troiano, G., Lo Russo, L., DE Lillo, A., Laino, L., & Lo Muzio, L. (2015). Biological and therapeutic activities, and anticancer properties of curcumin. Experimental and therapeutic medicine, 10(5), 1615–1623. https://doi.org/10.3892/etm.2015.2749
Rana, S., Lemoine, E., Granger, J. P., & Karumanchi, S. A. (2019). Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circulation research, 124(7), 1094–1112. https://doi.org/10.1161/CIRCRESAHA.118.313276
Redman, C. W., & Staff, A. C. (2015). Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. American Journal of Obstetrics and Gynecology, 213(4), S9.e1–S9.e10. https://doi.org/10.1016/j.ajog.2015.08.003
Rumbold, A. R., Crowther, C. A., Haslam, R. R., Dekker, G. A., Robinson, J. S., & ACTS Study Group (2006). Vitamins C and E and the risks of preeclampsia and perinatal complications. The New England journal of medicine, 354(17), 1796–1806. https://doi.org/10.1056/NEJMoa054186
Russell, W. M. S., & Burch, R. L. (1959). The principles of humane experimental technique. Methuen.
Sánchez-Aranguren, L. C., Prada, C. E., Riaño-Medina, C. E., & Lopez, M. (2014). Endothelial dysfunction and preeclampsia: role of oxidative stress. Frontiers in physiology, 5, 372. https://doi.org/10.3389/fphys.2014.00372
Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2019). Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules (Basel, Switzerland), 24(8), 1583. https://doi.org/10.3390/molecules24081583
Vaka, V. R., McMaster, K. M., Cunningham, M. W., Jr, Ibrahim, T., Hazlewood, R., Usry, N., Cornelius, D. C., Amaral, L. M., & LaMarca, B. (2018). Role of Mitochondrial Dysfunction and Reactive Oxygen Species in Mediating Hypertension in the Reduced Uterine Perfusion Pressure Rat Model of Preeclampsia. Hypertension (Dallas, Tex. : 1979), 72(3), 703–711. https://doi.org/10.1161/HYPERTENSIONAHA.118.11290
Wang, J. B., Qi, L. L., Zheng, S. D., & Wu, T. X. (2009). Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells. Journal of Zhejiang University. Science. B, 10(2), 93–102. https://doi.org/10.1631/jzus.B0820238
World Health Organization. 2017. Maternal Mortality. Available from: https://www.who.int/news-room/fact-sheets/detail/maternal-mortality
Youshia, J., Gabal, Y. M., Mansour, M., & Gad, H. A. (2023). Curcumin-loaded nanoparticles in neurodegenerative diseases. In M. Rai & C. M. Feitosa (Eds.), Curcumin and neurodegenerative diseases (pp. 1-17). Springer. https://doi.org/10.1007/978-981-99-7731-4_17

Rights and permissions

© The Author(s) 2025
Open Access This article is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which permits others to share, adapt, and redistribute the material in any medium or format, even for commercial purposes, provided appropriate credit is given to the original author(s) and the source, a link to the license is provided, and any changes made are indicated. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. To view a copy of this license, visit https://creativecommons.org/licenses/by-sa/4.0/.

PDF

Keywords

Nanocurcumin
Malondiadehyde
Preeclampsia
oxidative stress
antioxidant

Author Information

dr. Subandi, SpOG(K)

Departmen Kebidanan, Fakultas Kedokteran, Universitas Brawijaya, Indonesia, Indonesia.

Laras Indah Sari

Program Sarjana Program Studi Kebidanan, Fakultas Kedokteran, Universitas Brawijaya, Indonesia, Indonesia.

ORCID : https://orcid.org/0009-0004-9132-4613

Prof. Dr. dr. Nurdiana, M.Kes

Department of Pharmacology, Faculty of Medicine, Universitas Brawijaya, Indonesia.

Article History

Submitted: 21 August 2024
Accepted: 23 February 2025
Published: 9 January 2025

How to Cite This

Subandi, S., Sari, L. I., & Nurdiana, N. (2025). The Effect of Nanocurcumin Administration on Plasma Malondialdehyde (MDA) Levels in Pregnant Wistar Rats (Rattus norvegicus) as a Preeclampsia Model: Pengaruh Pemberian Nano Kurkumin terhadap Kadar Malondialdehyde (MDA) Plasma Darah Pada Tikus Wistar (Rattus norvegicus) Bunting Model Preeklampsia. Majalah Kesehatan Indonesia, 6(1), 35–42. https://doi.org/10.47679/makein.2025226